- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.06. | FDA issues untitled letter after finding 'eye-catching graphics' in promotional emails | ||
| 03.06. | Neurotech launches new YouTube channel to spotlight patients' stories for rare eye disorder | ||
| 02.06. | Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts | ||
| 02.06. | Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances | ||
| 02.06. | Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population | ||
| 02.06. | Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens: report | ||
| 02.06. | Sanofi taps Snowflake for AI field agent help | ||
| 02.06. | ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection | ||
| 02.06. | Eisai whips up Alzheimer's dietary guidance to expand nutrition program beyond cancer | ||
| 02.06. | Regulatory tracker: J&J grows Tremfya label stateside; AbbVie nets EU Venclyxto expansion | ||
| 01.06. | How HER2 biology is shaping next-generation cancer treatment | ||
| 01.06. | Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative | ||
| 01.06. | ViiV Healthcare launches 'PrEP Wisdom' campaign to boost awareness of long-acting HIV prevention meds | ||
| 31.05. | ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% | ||
| 29.05. | Pharma urged to modernize patient support as young adult cancer rates rise | ||
| 29.05. | Philips adds a spoonful of Disney sugar to ease kids' MRI anxieties | ||
| 28.05. | AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi | ||
| 28.05. | Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge | ||
| 28.05. | CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo | ||
| 28.05. | PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion | ||
| 28.05. | Kaléo speaks up on allergy awareness to amplify patient stories | ||
| 27.05. | Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal | ||
| 27.05. | ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary | ||
| 27.05. | As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey | ||
| 27.05. | Eli Lilly wins argument over Noom's GLP-1 dosing claims |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.